Tech Company M&A Transactions
Enobia Pharma Acquisition
Enobia Pharma, operating out of Cambridge, was acquired by Alexion Pharmaceuticals. The acquisition price was $1.1 billion.
Transaction Overview
Company Name
Acquired By
Announced On
12/29/2011
Transaction Type
M&A
Amount
$1,080,000,000
M&A Terms
Alexion has agreed to pay $610 million in cash upon consummation of the transaction, and up to $470 million in cash to be paid upon achievement of various regulatory and sales milestones. Alexion is not issuing equity in connection with the acquisition.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
55 Cambridge Parkway 800
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Not Recorded
Overview
Enobia Pharma is a developer of enzyme replacement therapies for the treatment of serious bone diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Heft
Chief Financial Officer
Jeff Mack
Chief Medical Officer
Hal Landy
Chief Scientific Officer
Philippe Crine
VP - Finance
Luc Cournoyer
VP - General Counsel
Eric Trachtenberg
VP - Manufacturing
Bernhard Eggimann
VP - Regulatory Affairs
Deborah Ramsdell
Browse more venture capital transactions:
Prev: 12/29/2011: TodoCast venture capital transaction
Next: 12/29/2011: Uptake Medical venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs